Turn­stone stops TIL stud­ies; GH Re­search’s $150M of­fer­ing

Plus, news about Au­ron Ther­a­peu­tics, Akribion Ther­a­peu­tics, En­ver­ic Bio­sciences and Va­le­rio Ther­a­peu­tics:

Turn­stone Bi­o­log­ics to dis­con­tin­ue TIL stud­ies, “re­view strate­gic al­ter­na­tives”: The com­pa­ny

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER